MICHELE YOUNG: Open Payments
NPI 1306963046 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 17 payments from 12 companies in 2025. Trend: 2023 $678 · 2024 $202 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $134 |
| ABBVIE INC. | 4 | $113 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| PFIZER INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| TerSera Therapeutics LLC | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| ARRAY BIOPHARMA INC | 1 | $22 |
Products named: Jakafi, Padcev, KISQALI, VENCLEXTA, ELAHERE, BLENREP, Zoladex, DARZALEX.
Industry payments across FL — which companies pay providers there.
